Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

Icad Inc (ICAD)

Icad Inc (ICAD)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.98 -0.08 (-3.88%) 04/01/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 2.01 +0.03 (+1.52%) 19:28 ET
Quote Overview for Tue, Apr 1st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.95
Day High
2.09
Open 1.96
Previous Close 2.06 2.06
Volume 317,700 317,700
Avg Vol 277,125 277,125
Stochastic %K 16.02% 16.02%
Weighted Alpha -8.64 -8.64
5-Day Change -0.29 (-12.78%) -0.29 (-12.78%)
52-Week Range 1.18 - 3.78 1.18 - 3.78
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 54,672
  • Shares Outstanding, K 26,540
  • Annual Sales, $ 19,610 K
  • Annual Income, $ -5,620 K
  • EBIT $ -5 M
  • EBITDA $ -7 M
  • 60-Month Beta 1.95
  • Price/Sales 2.90
  • Price/Cash Flow N/A
  • Price/Book 1.93

Options Overview Details

View History
  • Implied Volatility 116.57% ( -21.77%)
  • Historical Volatility 74.67%
  • IV Percentile 18%
  • IV Rank 27.31%
  • IV High 324.34% on 05/03/24
  • IV Low 38.52% on 08/23/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 78
  • Volume Avg (30-Day) 126
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 2,966
  • Open Int (30-Day) 3,496

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.15
  • Growth Rate Est. (year over year) +666,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.95 +1.54%
on 04/01/25
Period Open: 2.41
2.67 -25.84%
on 03/03/25
-0.43 (-17.84%)
since 02/28/25
3-Month
1.75 +13.14%
on 01/13/25
Period Open: 1.83
3.78 -47.62%
on 01/30/25
+0.15 (+8.20%)
since 12/31/24
52-Week
1.18 +67.80%
on 07/05/24
Period Open: 1.52
3.78 -47.62%
on 01/30/25
+0.46 (+30.26%)
since 04/01/24

Most Recent Stories

More News
Icad: Q4 Earnings Snapshot

Icad: Q4 Earnings Snapshot

ICAD : 1.98 (-3.88%)
iCAD Reports Financial Results for Fourth Quarter and Fiscal Year Ended December 31, 2024

ICAD : 1.98 (-3.88%)
iCAD to Report Fourth Quarter and Full Year 2024 Financial Results on March 19, 2025

ICAD : 1.98 (-3.88%)
iCAD and RamSoft Announce Partnership to Deliver ProFound® AI-Powered Mammography Solutions Across North America

ICAD : 1.98 (-3.88%)
Koios Medical and iCAD Partner to Expand AI-Powered, Multi-Modality Breast Cancer Detection Solutions at ECR 2025

ICAD : 1.98 (-3.88%)
iCAD To Showcase Five AI-Powered Research Presentations Advancing Breast Cancer Detection, Risk Evaluation, and Breast Arterial Calcification Assessment at ECR 2025

ICAD : 1.98 (-3.88%)
AI in Healthcare Sees Explosive Growth: Key Innovations Investors Should Watch

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – Just weeks after the groundbreaking $500-billion announcement of Project Stargate, which aims to redefine...

AVAI : 0.3700 (-22.92%)
VSEE : 1.2100 (+0.83%)
WDAY : 234.53 (+0.43%)
BFLY : 2.22 (-2.63%)
ICAD : 1.98 (-3.88%)
Potential Revolution in Healthcare Brewing, Powered by AI Innovation

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – The United States is poised for a transformative leap in AI innovation as President Trump unveiled a...

NVDA : 110.15 (+1.63%)
AVAI : 0.3700 (-22.92%)
NVO : 68.03 (-2.03%)
ORCL : 141.94 (+1.52%)
IQV : 171.24 (-2.87%)
ICAD : 1.98 (-3.88%)
iCAD Pre-Announces Estimated Q4 2024 Revenue

ICAD : 1.98 (-3.88%)
Zacks Market Edge Highlights: FiscalNote, and iCAD

For Immediate ReleaseChicago, IL – January 21, 2025 – Zacks Market Edge is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the...

NOTE : 0.7800 (-3.48%)
ICAD : 1.98 (-3.88%)

Business Summary

Icad, Inc. designs, engineers, develops and manufactures digital image scanners, densitometers, film digitizers and related software for applications in the graphic arts, medical imaging and life sciences markets. The Company sells its products throughout the world throughvarious distributors, resellers,...

See More

Key Turning Points

3rd Resistance Point 2.20
2nd Resistance Point 2.15
1st Resistance Point 2.06
Last Price 1.98
1st Support Level 1.92
2nd Support Level 1.87
3rd Support Level 1.78

See More

52-Week High 3.78
Fibonacci 61.8% 2.79
Fibonacci 50% 2.48
Fibonacci 38.2% 2.17
Last Price 1.98
52-Week Low 1.18

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies